Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex

scientific article published on March 13, 1992

Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCIENCE.1371891
P8608Fatcat IDrelease_el7fpb5gnfhu7lip4g5i54zgru
P698PubMed publication ID1371891

P50authorRobert GalloQ469904
P2093author name stringS. Nakamura
R. C. Gallo
Y. Osada
M. Sekiguchi
N. Sakamoto
N. G. Tanaka
S. Sakurada
S. Z. Salahuddin
P433issue5050
P407language of work or nameEnglishQ1860
P921main subjectcell wallQ128700
peptidoglycanQ206920
P304page(s)1437-1440
P577publication date1992-03-01
1992-03-13
P1433published inScienceQ192864
P1476titleInhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex
P478volume255

Reverse relations

cites work (P2860)
Q24678972AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies
Q40925893AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approaches
Q33948194Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
Q40915770Advances in Kaposi's sarcoma
Q41508935An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
Q72076470Analysis of experimental antiangiogenic therapy
Q72680667Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus
Q35366050Antiviral therapy for human immunodeficiency virus infections
Q36363956Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice
Q34155667Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
Q73147184Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model
Q48506360Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture
Q44270368Do more than discuss that unusual case. Write it up!
Q41498045Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors
Q35489176Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock
Q41648545Inhibition of malignant angiogenesis
Q55472387Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461.
Q71804597Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and non-haematogenous tumour cells in mice
Q46661407Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome
Q40987325Kaposi's sarcoma: advances and perspectives
Q35752847Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis
Q27729397Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor
Q72093201Treatment of Kaposi's sarcoma
Q40395719Treatment of Kaposi's sarcoma. Current guidelines and future perspectives
Q35215799Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth
Q73164417[Anti-angiogenesis: a new approach to tumor therapy?]

Search more.